Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$265.58-0.77 (-0.29%)
Delayed quote: Sep 11, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 11, 2026, 4:00 PM EDT
Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-14T13:15:51.167Z.
Calculation as of: 2026-09-14T13:15:51.167Z.
Quote observation: 2026-09-11T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c5d71939891d50f43b477f3dd23b47cf8ea98804d756fac9b811a8bcf6d5e23f
PEG RATIO
N/A
Johnson & Johnson
Market Cap
$640.02B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Johnson & Johnson (JNJ) | $640.02B | N/A |
| Pfizer Inc. (PFE)vs › | $157.99B | N/A |
| Merck & Co., Inc. (MRK)vs › | $355.49B | N/A |
| AbbVie Inc. (ABBV)vs › | $454.17B | N/A |
| Eli Lilly and Company (LLY)vs › | $1.05T | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $130.00B | N/A |
PEG Ratio
N/A
P/E Ratio
30.8
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute